Type I collagen turnover is a critical parameter for melanoma progression

Léon C.L.T. van Kempen(Vrije Universiteit Brussel), Goos van Muijen, D. J. Ruiter(Radboud University Nijmegen), Claudine Geffrotin(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Ine Mamor‐Cornelissen, Jos Rijntjes(Radboud University Nijmegen), M. Gerritsen(Radboud University Nijmegen), M. van Dijk, Silvia Vincent‐Naulleau(Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Melanoma Research
September 1, 2006
10.1097/00008390-200609001-00128
Cited by 2

Related Papers

N-ras mutations in human cutaneous melanoma from sun-exposed body sites.
|Molecular and Cellular Biology|1989|280
Aneurysmal bone cysts.A clinicopathological study of 105 cases
|Cancer|1977|269
c‐myc down‐regulates class I HLA expression in human melanomas.
|The EMBO Journal|1988|257
Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.
|Journal of Clinical Oncology|1998|246
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial
|European Journal of Cancer|2003|240